全文获取类型
收费全文 | 1648873篇 |
免费 | 139214篇 |
国内免费 | 6745篇 |
专业分类
耳鼻咽喉 | 22077篇 |
儿科学 | 53417篇 |
妇产科学 | 46729篇 |
基础医学 | 232996篇 |
口腔科学 | 48064篇 |
临床医学 | 146909篇 |
内科学 | 320701篇 |
皮肤病学 | 34597篇 |
神经病学 | 132338篇 |
特种医学 | 66587篇 |
外国民族医学 | 494篇 |
外科学 | 248678篇 |
综合类 | 51036篇 |
现状与发展 | 13篇 |
一般理论 | 546篇 |
预防医学 | 126921篇 |
眼科学 | 37660篇 |
药学 | 126865篇 |
40篇 | |
中国医学 | 7022篇 |
肿瘤学 | 91142篇 |
出版年
2018年 | 16515篇 |
2016年 | 14547篇 |
2015年 | 17502篇 |
2014年 | 23522篇 |
2013年 | 34132篇 |
2012年 | 46045篇 |
2011年 | 48574篇 |
2010年 | 29015篇 |
2009年 | 27379篇 |
2008年 | 45359篇 |
2007年 | 47979篇 |
2006年 | 48628篇 |
2005年 | 46918篇 |
2004年 | 46588篇 |
2003年 | 45279篇 |
2002年 | 44053篇 |
2001年 | 77866篇 |
2000年 | 79732篇 |
1999年 | 67350篇 |
1998年 | 18366篇 |
1997年 | 16915篇 |
1996年 | 16702篇 |
1995年 | 16375篇 |
1994年 | 15373篇 |
1993年 | 14391篇 |
1992年 | 55617篇 |
1991年 | 53943篇 |
1990年 | 52712篇 |
1989年 | 50963篇 |
1988年 | 47314篇 |
1987年 | 46645篇 |
1986年 | 44347篇 |
1985年 | 42903篇 |
1984年 | 32052篇 |
1983年 | 27584篇 |
1982年 | 16152篇 |
1981年 | 14451篇 |
1980年 | 13573篇 |
1979年 | 30465篇 |
1978年 | 21064篇 |
1977年 | 17764篇 |
1976年 | 16694篇 |
1975年 | 17574篇 |
1974年 | 21486篇 |
1973年 | 20672篇 |
1972年 | 18853篇 |
1971年 | 17770篇 |
1970年 | 16281篇 |
1969年 | 15250篇 |
1968年 | 13936篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Kinase alterations are increasingly recognised as oncogenic drivers in mesenchymal tumours. Infantile fibrosarcoma and the related renal tumour, congenital mesoblastic nephroma, were among the first solid tumours shown to harbour recurrent tyrosine kinase fusions, with the canonical ETV6::NTRK3 fusion identified more than 20 years ago. Although targeted testing has long been used in diagnosis, the advent of more robust sequencing techniques has driven the discovery of kinase alterations in an array of mesenchymal tumours. As our ability to identify these genetic alterations has improved, as has our recognition and understanding of the tumours that harbour these alterations. Specifically, this study will focus upon mesenchymal tumours harbouring NTRK or other kinase alterations, including tumours with an infantile fibrosarcoma-like appearance, spindle cell tumours resembling lipofibromatosis or peripheral nerve sheath tumours and those occurring in adults with a fibrosarcoma-like appearance. As publications describing the histology of these tumours increase so, too, do the variety kinase alterations reported, now including NTRK1/2/3, RET, MET, RAF1, BRAF, ALK, EGFR and ABL1 fusions or alterations. To date, these tumours appear locally aggressive and rarely metastatic, without a clear link between traditional features used in histological grading (e.g. mitotic activity, necrosis) and outcome. However, most of these tumours are amenable to new targeted therapies, making their recognition of both diagnostic and therapeutic import. The goal of this study is to review the clinicopathological features of tumours with NTRK and other tyrosine kinase alterations, discuss the most common differential diagnoses and provide recommendations for molecular confirmation with associated treatment implications. 相似文献
2.
3.
4.
5.
6.
Qian Zhang Larry D. Mesner Gina M. Calabrese Naomi Dirckx Zhu Li Angela Verardo Qian Yang Robert J. Tower Marie-Claude Faugere Charles R. Farber Thomas L. Clemens 《The Journal of clinical investigation》2021,131(7)
Bone mineral density (BMD) is a highly heritable predictor of osteoporotic fracture. GWAS have identified hundreds of loci influencing BMD, but few have been functionally analyzed. In this study, we show that SNPs within a BMD locus on chromosome 14q32.32 alter splicing and expression of PAR-1a/microtubule affinity regulating kinase 3 (MARK3), a conserved serine/threonine kinase known to regulate bioenergetics, cell division, and polarity. Mice lacking Mark3 either globally or selectively in osteoblasts have increased bone mass at maturity. RNA profiling from Mark3-deficient osteoblasts suggested changes in the expression of components of the Notch signaling pathway. Mark3-deficient osteoblasts exhibited greater matrix mineralization compared with controls that was accompanied by reduced Jag1/Hes1 expression and diminished downstream JNK signaling. Overexpression of Jag1 in Mark3-deficient osteoblasts both in vitro and in vivo normalized mineralization capacity and bone mass, respectively. Together, these findings reveal a mechanism whereby genetically regulated alterations in Mark3 expression perturb cell signaling in osteoblasts to influence bone mass. 相似文献
7.
8.
9.
目的 运用CT区分脾脏血管性病变与淋巴瘤。方法 回顾性分析20例经手术、穿刺病理学检查证实的脾脏病变的发病年龄、性别、脾脏指数、病变大小、数目、有无液化、钙化、强化幅度、强化方式等特征,并进行统计学分析。结果 20例脾脏病变中,11例血管性病变(6例海绵状血管瘤,3例窦岸细胞血管瘤,2例硬化性血管瘤样结节性转化),9例淋巴瘤;两组间发病年龄、病变大小、数目、有无液化、钙化等差异无统计学意义;两组间脾脏指数、动脉期强化幅度差异具有统计学意义(P<0.05)。5例海绵状血管瘤呈不均匀性强化,1例呈渐进性填充式强化,2例窦岸细胞血管瘤呈“雀斑征”,1例硬化性血管瘤样结节性转化呈“辐轮征”;9例淋巴瘤实质部分均呈均匀、轻中度强化。结论 脾脏血管性病变与淋巴瘤CT表现不同,CT有助于明确诊断。 相似文献
10.